glp‑1 diagnostics demand
GLP-1 / Weight‑Loss Drugs Cause 27% Cost Spike
GLP-1 weight-loss drugs have driven a 27% increase in baseline metabolic panel charges, lifting the average claim from $140 to $210 and inflating diagnostics budgets by 28% over the past year. 2024 marks a turning point: every new GLP-1 prescription triggers a cascade of lab orders that hospitals must absorb,